Balyasny Asset Management LLC Takeda Pharmaceutical CO LTD Transaction History

Balyasny Asset Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$13.89 - $15.04 $213,267 - $230,924	15,354 New	15,354 $213,000
Q3 2023 Nov 14, 2023	SELL	$15.03 - $16.32 $185,440 - $201,356	-12,338 Reduced 37.0%	21,007 $324,000
Q2 2023 Aug 14, 2023	BUY	$15.57 - $17.11 $519,181 - $570,532	33,345 New	33,345 $523,000
Q3 2022 Nov 14, 2022	BUY	$12.8 - $28.65 $533,580 - $1.19 Million	41,686 Added 280.98%	56,522 $733,000
Q2 2022 Aug 15, 2022	BUY	$13.12 - $15.03 $194,648 - $222,985	14,836 New	14,836 $208,000
Q3 2021 Nov 15, 2021	SELL	$16.3 - $17.26 $956,435 - $1.01 Million	-58,677 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$16.55 - $18.64 $971,104 - $1.09 Million	58,677 New	58,677 $988,000
Q2 2020 Aug 14, 2020	SELL	$14.59 - $19.5 $231,163 - $308,958	-15,844 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$13.02 - $20.31 $206,288 - $321,791	15,844 New	15,844 $241,000
Q2 2019 Aug 14, 2019	SELL	$16.58 - $20.49 $5.72 Million - $7.06 Million	-344,714 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $5.76 Million - $7.42 Million	344,714 New	344,714 $7.02 Million

336

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.3B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.